BioCryst Pharmaceuticals Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| CSL | CSL | Outperform |
12
|
$280.00 | $205.51 | -26.66% | 5 | $135.31B |
| 4568 | Daiichi Sankyo Company | Buy |
4
|
¥5.53k | ¥5.24k | 7.58% | 0 | ¥10.60T |
| 4502 | Takeda Pharmaceutical Company | Outperform |
5
|
¥4.13k | ¥4.74k | 8.96% | 0 | ¥6.48T |
| BMRN | BioMarin Pharmaceutical | Outperform |
10
|
$77.56 | $111.56 | 42.47% | 5 | $14.62B |
| 4507 | Shionogi & | Outperform |
18
|
¥7.13k | ¥7.12k | 12.22% | 0 | ¥2.16T |
| IONS | Ionis Pharmaceuticals | Outperform |
9
|
$37.31 | $55.60 | 60.81% | 3 | $5.76B |
| NTLA | Intellia Therapeutics | Outperform |
8
|
$26.22 | $75.84 | 166.97% | 21 | $2.36B |
| PHARM | Pharming Group N.V. | Buy |
16
|
0.85€ | 1.85€ | 141.18% | 2 | 591.95€M |
| KALV | KalVista Pharmaceuticals | Buy |
7
|
$11.92 | $20.80 | 193.62% | 0 | $478.84M |